OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Mukhtar Ahmed is Vice President, Product Strategy, Oracle Health Sciences.
The latest news on the growing cost of conducting clinical trials is becoming a major concern for company sponsors and trial co-operative groups.
Mukhtaer Ahmed outlines how advances in machine-to-machine (M2M) technologies have the potential to transform clinical development programs, including clinical trials.